Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Crohn's Disease Topic Center

Featured Content

News
Ustekinumab Shows Superior Persistance in CD Patients With Prior Biologic Use
08/26/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
08/26/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/12/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/12/2024
Advances in Inflammatory Bowel Disease Network
Ray Cross
Conference Coverage
Raymond Cross, MD, on Drug Positioning in Crohn's Disease
08/08/2024
Dr Cross reviewed the options for treatment for Crohn's disease, including the many drug options now available and using comparative effectiveness to help positioning therapeutics.
Dr Cross reviewed the options for treatment for Crohn's disease, including the many drug options now available and using comparative effectiveness to help positioning therapeutics.
Dr Cross reviewed the options...
08/08/2024
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Video
Miguel Regueiro, MD, on Perianal and Fistulizing Crohn's Disease
07/15/2024
Dr Regueiro gives highlights of his talk at Digestive Disease Week on the challenges of perianal and fistulizing Crohn's disease and some of the options available for treatment.
Dr Regueiro gives highlights of his talk at Digestive Disease Week on the challenges of perianal and fistulizing Crohn's disease and some of the options available for treatment.
Dr Regueiro gives highlights of...
07/15/2024
Advances in Inflammatory Bowel Disease Network
Video
Joelle St Pierre, MD, on the Chicago Mesenteric Fat Index
07/11/2024
Dr St Pierre discusses the award-winning poster she presented at Digestive Disease Week on the Chicago Mesenteric Fat Index, which proved a reliable measure that can be incorporated in point-of-care intestinal ultrasound in the care of IBD...
Dr St Pierre discusses the award-winning poster she presented at Digestive Disease Week on the Chicago Mesenteric Fat Index, which proved a reliable measure that can be incorporated in point-of-care intestinal ultrasound in the care of IBD...
Dr St Pierre discusses the...
07/11/2024
Advances in Inflammatory Bowel Disease Network
Remo Pannaccione
Video
Remo Panaccione, MD, on the GALAXI Trials of Guselkumab
06/17/2024
Dr Panaccione reviews the results of the GALAXI 2 and 3 trials of guselkumab for treatment of Crohn's disease, which he presented at Digestive Disease Week 2024.
Dr Panaccione reviews the results of the GALAXI 2 and 3 trials of guselkumab for treatment of Crohn's disease, which he presented at Digestive Disease Week 2024.
Dr Panaccione reviews the...
06/17/2024
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Video
Edward Loftus, MD, on Upadacitinib in Crohn's Disease
06/06/2024
Dr Loftus recaps his poster presentation on a subanalysis from the upadacitinib phase 3 trials in Crohn's disease examining the effect on anxiety, depression, fatigue, and bowel urgency.
Dr Loftus recaps his poster presentation on a subanalysis from the upadacitinib phase 3 trials in Crohn's disease examining the effect on anxiety, depression, fatigue, and bowel urgency.
Dr Loftus recaps his poster...
06/06/2024
Advances in Inflammatory Bowel Disease Network
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on Postoperative Crohn's Disease
05/15/2024
Dr Regueiro recaps his keynote address on the management postoperative Crohn's disease, including new surgical techniques and medications that could help prevent the occurrence of postoperative disease.
Dr Regueiro recaps his keynote address on the management postoperative Crohn's disease, including new surgical techniques and medications that could help prevent the occurrence of postoperative disease.
Dr Regueiro recaps his keynote...
05/15/2024
Advances in Inflammatory Bowel Disease Network
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
Florian Rieder
Videos
Florian Rieder, MD, on Positioning Drugs in Crohn's Disease
04/26/2024
Dr Florian Rieder from Cleveland Clinic spoke at the AIBD Regional Meeting on how he approaches positioning different therapies among patients with Crohn's disease.
Dr Florian Rieder from Cleveland Clinic spoke at the AIBD Regional Meeting on how he approaches positioning different therapies among patients with Crohn's disease.
Dr Florian Rieder from Cleveland...
04/26/2024
Advances in Inflammatory Bowel Disease Network

News

News
Ustekinumab Shows Superior Persistance in CD Patients With Prior Biologic Use
08/26/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
08/26/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/12/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
News
Prognosis of CD-Associated Anorectal Cancer Studied
02/12/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Investigators examined the prognosis and clinicopathological features of Crohn’s disease-associated colorectal cancer (CRC) compared with sporadic CRC.
Investigators examined the prognosis and clinicopathological features of Crohn’s disease-associated colorectal cancer (CRC) compared with sporadic CRC.
Investigators examined the...
02/12/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
02/07/2024

Jolynn Tumolo

Jolynn Tumolo
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
02/07/2024
Gastroenterology
News
Biological Changes Apparent Years Before CD Diagnosis
01/30/2024

Jolynn Tumolo

Jolynn Tumolo
C-reactive protein and other parameters can show indications of Crohn’s disease up to 8 years before diagnosis.
C-reactive protein and other parameters can show indications of Crohn’s disease up to 8 years before diagnosis.
C-reactive protein and other...
01/30/2024
Gastroenterology
News
AGA Guideline Advises Fecal Calprotectin, CRP Monitoring in Crohn’s Disease
01/05/2024

Jolynn Tumolo

Jolynn Tumolo
New guidance focuses on disease management for both asymptomatic and symptomatic patients.
New guidance focuses on disease management for both asymptomatic and symptomatic patients.
New guidance focuses on disease...
01/05/2024
Advances in Inflammatory Bowel Disease Network
News
Does Gut Microbiome Contribute to — or Result From — Crohn’s Disease?
11/30/2023

Rebecca Mashaw, Digital Managing Editor

 

Rebecca Mashaw, Digital Managing Edit...
Investigators look at whether altered microbiome is a cause or a result of Crohn’s disease and its treatment.
Investigators look at whether altered microbiome is a cause or a result of Crohn’s disease and its treatment.
Investigators look at whether...
11/30/2023
Advances in Inflammatory Bowel Disease Network
News
Risankizumab, Infliximab Show Best Efficacy for Inducing Remission of Crohn’s Disease
10/17/2023

Jolynn Tumolo

Jolynn Tumolo
Risankizumab scored best for biologic-naïve and biologic-exposed patients in induction of remission but infliximab came out ahead for all patients, according to a report in Gut.
Risankizumab scored best for biologic-naïve and biologic-exposed patients in induction of remission but infliximab came out ahead for all patients, according to a report in Gut.
Risankizumab scored best for...
10/17/2023
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistance in CD Patients With Prior Biologic Use
08/26/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
08/26/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/12/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
News
Study Finds Higher-Than-Expected IBD Rates in US Black Women
05/02/2024

Jolynn Tumolo

Jolynn Tumolo
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory...
05/02/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Subcutaneous Vedolizumab for Maintenance Therapy in Crohn’s Disease
04/22/2024
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug...
04/22/2024
Advances in Inflammatory Bowel Disease Network
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Post-Menopausal Women With IBD and Hormone Replacement Therapy
04/05/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to...
04/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network

Interactive Features

medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
doc writing notes
Quiz
SIBO and Crohn's Disease
04/28/2023
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small...
04/28/2023
Advances in Inflammatory Bowel Disease Network
quiz
Quiz
Does Crohn's Disease or Ulcerative Colitis Present the Highest Risk of Multiple EIMs?
12/11/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Extraintestinal manifestations (EIMs) are seen in 25-40% of patients with inflammatory bowel disease. Take a quick quiz to find out who is more at risk of developing multiple EIMs.
Extraintestinal manifestations (EIMs) are seen in 25-40% of patients with inflammatory bowel disease. Take a quick quiz to find out who is more at risk of developing multiple EIMs.
Extraintestinal manifestations...
12/11/2023
Advances in Inflammatory Bowel Disease Network
light bulb+quiz
Quiz
Positioning Diet for Crohn's Disease
09/04/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
David Rubin, MD, explained some key differences between the different diets in the management of Crohn's disease to achieve the best possible outcomes. Do you know what diet is the most palatable and sustainable? Take our quiz to find out!
David Rubin, MD, explained some key differences between the different diets in the management of Crohn's disease to achieve the best possible outcomes. Do you know what diet is the most palatable and sustainable? Take our quiz to find out!
David Rubin, MD, explained some...
09/04/2023
Advances in Inflammatory Bowel Disease Network
quiz
Quiz
The 3 Pillars of IBD Care
07/18/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Do you know the essential principles of management of inflammatory bowel disease? Take a quick quiz to find out!
Do you know the essential principles of management of inflammatory bowel disease? Take a quick quiz to find out!
Do you know the essential...
07/18/2023
Advances in Inflammatory Bowel Disease Network
medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
Quiz
Role of Biologic Agents in IBD
06/14/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Are biologic agents the ultimate answer in the treatment of intestinal inflammation? Test your knowledge here!
Are biologic agents the ultimate answer in the treatment of intestinal inflammation? Test your knowledge here!
Are biologic agents the ultimate...
06/14/2023
Advances in Inflammatory Bowel Disease Network
coffee+quiz
Quiz
Resection or Medical Therapy for Early Ileocecal Crohn Disease?
05/24/2023
Experts explored the possibility of resection for patients with Crohn disease in the early stages. What did they conclude? Take our quiz to test your knowledge!
Experts explored the possibility of resection for patients with Crohn disease in the early stages. What did they conclude? Take our quiz to test your knowledge!
Experts explored the possibility...
05/24/2023
Advances in Inflammatory Bowel Disease Network
doc writing notes
Quiz
SIBO and Crohn's Disease
04/28/2023
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small...
04/28/2023
Advances in Inflammatory Bowel Disease Network
Clostridioides difficile
Quiz
Increased Risk of Clostridioides difficile Among Patients with IBD
04/01/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
In her presentation at the virtual Advances in Inflammatory Bowel Disease meeting on April 30, Monika Fischer, MD, stated, “Individuals with IBD [inflammatory bowel disease] are at 5-fold risk of getting CDI [Clostridioides difficile], more...
In her presentation at the virtual Advances in Inflammatory Bowel Disease meeting on April 30, Monika Fischer, MD, stated, “Individuals with IBD [inflammatory bowel disease] are at 5-fold risk of getting CDI [Clostridioides difficile], more...
In her presentation at the...
04/01/2023
Advances in Inflammatory Bowel Disease Network
OR shot
Quiz
Colectomy Rates Among Patients With UC
02/22/2023
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates...
02/22/2023
Advances in Inflammatory Bowel Disease Network
colonoscopy
Quiz
Endoscopic Healing in Crohn Disease
07/04/2022
A recent study compared the rates of endoscopic healing after 1 year of therapy with different classes of medications. Do you know which won out? Take our quiz to find out!
A recent study compared the rates of endoscopic healing after 1 year of therapy with different classes of medications. Do you know which won out? Take our quiz to find out!
A recent study compared the...
07/04/2022
Advances in Inflammatory Bowel Disease Network

Insights

Ed Loftus
Video
Edward Loftus, MD, on Upadacitinib in Crohn's Disease
06/06/2024
Dr Loftus recaps his poster presentation on a subanalysis from the upadacitinib phase 3 trials in Crohn's disease examining the effect on anxiety, depression, fatigue, and bowel urgency.
Dr Loftus recaps his poster presentation on a subanalysis from the upadacitinib phase 3 trials in Crohn's disease examining the effect on anxiety, depression, fatigue, and bowel urgency.
Dr Loftus recaps his poster...
06/06/2024
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on Postoperative Crohn's Disease
05/15/2024
Dr Regueiro recaps his keynote address on the management postoperative Crohn's disease, including new surgical techniques and medications that could help prevent the occurrence of postoperative disease.
Dr Regueiro recaps his keynote address on the management postoperative Crohn's disease, including new surgical techniques and medications that could help prevent the occurrence of postoperative disease.
Dr Regueiro recaps his keynote...
05/15/2024
Advances in Inflammatory Bowel Disease Network
Florian Rieder
Videos
Florian Rieder, MD, on Positioning Drugs in Crohn's Disease
04/26/2024
Dr Florian Rieder from Cleveland Clinic spoke at the AIBD Regional Meeting on how he approaches positioning different therapies among patients with Crohn's disease.
Dr Florian Rieder from Cleveland Clinic spoke at the AIBD Regional Meeting on how he approaches positioning different therapies among patients with Crohn's disease.
Dr Florian Rieder from Cleveland...
04/26/2024
Advances in Inflammatory Bowel Disease Network
Jordan Axelrad
Video
Jordan Axelrad, MD, on Postoperative Crohn's Disease
04/26/2024
Dr Jordan Axelrad reviews the key points of his presentation on postoperative management for patients with Crohn's disease from the AIBD Regional meeting in Chapel Hill, North Carolina.
Dr Jordan Axelrad reviews the key points of his presentation on postoperative management for patients with Crohn's disease from the AIBD Regional meeting in Chapel Hill, North Carolina.
Dr Jordan Axelrad reviews the...
04/26/2024
Advances in Inflammatory Bowel Disease Network
Stefan Holubar
Conference Coverage
Stefan Holubar, MD, on Perianal Crohn's Disease
04/12/2024
Dr Holubar reviews medical and surgical options for treating perianal Crohn's disease.
Dr Holubar reviews medical and surgical options for treating perianal Crohn's disease.
Dr Holubar reviews medical and...
04/12/2024
Advances in Inflammatory Bowel Disease Network
Florian Rieder
Video
Florian Rieder, MD, on Optimizing Outcomes in Crohn's DIsease
04/06/2024
Dr Rieder reviews the options for treatment of Crohn's disease in terms of safety, treatment of comorbidities, and efficacy for moderate to severe disease.
Dr Rieder reviews the options for treatment of Crohn's disease in terms of safety, treatment of comorbidities, and efficacy for moderate to severe disease.
Dr Rieder reviews the options...
04/06/2024
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Video
Miguel Regueiro, MD, on Association of IBD Therapies With Cardiovascular Events
11/15/2023
Dr Regueiro reviews research from Cleveland Clinic that took a closer look at whether biologics and small molecule therapies increase the risk of major cardiovascular events among patients with inflammatory bowel disease.
Dr Regueiro reviews research from Cleveland Clinic that took a closer look at whether biologics and small molecule therapies increase the risk of major cardiovascular events among patients with inflammatory bowel disease.
Dr Regueiro reviews research...
11/15/2023
Advances in Inflammatory Bowel Disease Network
Sara El Ouali
Conference Coverage
Non-Antitumor Necrosis Factor Biologics For Stricturing Crohn's Disease
11/10/2023

featuring Sara El Ouali, MD

featuring Sara El Ouali, MD
Dr El Ouali, from Cleveland Clinic Abu Dhabi, discusses research she and colleagues presented at DDW 2023 on the efficacy of non-antitumor necrosis factor biologics, including vedolizumab, in treatment of patients with stricturing Crohn's...
Dr El Ouali, from Cleveland Clinic Abu Dhabi, discusses research she and colleagues presented at DDW 2023 on the efficacy of non-antitumor necrosis factor biologics, including vedolizumab, in treatment of patients with stricturing Crohn's...
Dr El Ouali, from Cleveland...
11/10/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti
Video
Jessica Allegretti, MD, on Recent Advances in Anti-Interleukin Therapies
07/19/2024
Dr Allegretti provides key take-home points from her presentation at the AIBD regional meeting on how anti-interleukin therapies work to treat both Crohn's disease and ulcerative colitis,
Dr Allegretti provides key take-home points from her presentation at the AIBD regional meeting on how anti-interleukin therapies work to treat both Crohn's disease and ulcerative colitis,
Dr Allegretti provides key...
07/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Video
Edward Barnes, MD, on Updates in Ulcerative Colitis
07/17/2024
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on...
07/17/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Positioning Advanced Therapies for IBD
07/02/2024
Dr Rubin recaps his address at Digestive Disease Week on positioning advanced therapies in IBD, emphasizing the importance of assessing disease activity, prognosis for complications, and using a treat to target approach to achieve and...
Dr Rubin recaps his address at Digestive Disease Week on positioning advanced therapies in IBD, emphasizing the importance of assessing disease activity, prognosis for complications, and using a treat to target approach to achieve and...
Dr Rubin recaps his address at...
07/02/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
Laura Raffals
Video
Laura Raffals, MD, on Top Pearls for Managing Ulcerative Colitis
06/13/2024
Dr Raffals reviews her top pearls for ensuring patients with ulcerative colitis are correctly diagnosed, properly treated and monitored, and benefit from multidisciplinary care.
Dr Raffals reviews her top pearls for ensuring patients with ulcerative colitis are correctly diagnosed, properly treated and monitored, and benefit from multidisciplinary care.
Dr Raffals reviews her top...
06/13/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of ECCO With Dr Frank Farraye
06/12/2024
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of...
06/12/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest News

News
Ustekinumab Shows Superior Persistance in CD Patients With Prior Biologic Use
08/26/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
08/26/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/12/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
News
Prognosis of CD-Associated Anorectal Cancer Studied
02/12/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Investigators examined the prognosis and clinicopathological features of Crohn’s disease-associated colorectal cancer (CRC) compared with sporadic CRC.
Investigators examined the prognosis and clinicopathological features of Crohn’s disease-associated colorectal cancer (CRC) compared with sporadic CRC.
Investigators examined the...
02/12/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
02/07/2024

Jolynn Tumolo

Jolynn Tumolo
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
02/07/2024
Gastroenterology
News
Biological Changes Apparent Years Before CD Diagnosis
01/30/2024

Jolynn Tumolo

Jolynn Tumolo
C-reactive protein and other parameters can show indications of Crohn’s disease up to 8 years before diagnosis.
C-reactive protein and other parameters can show indications of Crohn’s disease up to 8 years before diagnosis.
C-reactive protein and other...
01/30/2024
Gastroenterology
News
AGA Guideline Advises Fecal Calprotectin, CRP Monitoring in Crohn’s Disease
01/05/2024

Jolynn Tumolo

Jolynn Tumolo
New guidance focuses on disease management for both asymptomatic and symptomatic patients.
New guidance focuses on disease management for both asymptomatic and symptomatic patients.
New guidance focuses on disease...
01/05/2024
Advances in Inflammatory Bowel Disease Network
News
Does Gut Microbiome Contribute to — or Result From — Crohn’s Disease?
11/30/2023

Rebecca Mashaw, Digital Managing Editor

 

Rebecca Mashaw, Digital Managing Edit...
Investigators look at whether altered microbiome is a cause or a result of Crohn’s disease and its treatment.
Investigators look at whether altered microbiome is a cause or a result of Crohn’s disease and its treatment.
Investigators look at whether...
11/30/2023
Advances in Inflammatory Bowel Disease Network
News
Risankizumab, Infliximab Show Best Efficacy for Inducing Remission of Crohn’s Disease
10/17/2023

Jolynn Tumolo

Jolynn Tumolo
Risankizumab scored best for biologic-naïve and biologic-exposed patients in induction of remission but infliximab came out ahead for all patients, according to a report in Gut.
Risankizumab scored best for biologic-naïve and biologic-exposed patients in induction of remission but infliximab came out ahead for all patients, according to a report in Gut.
Risankizumab scored best for...
10/17/2023
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistance in CD Patients With Prior Biologic Use
08/26/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
08/26/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/12/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
News
Study Finds Higher-Than-Expected IBD Rates in US Black Women
05/02/2024

Jolynn Tumolo

Jolynn Tumolo
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory...
05/02/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Subcutaneous Vedolizumab for Maintenance Therapy in Crohn’s Disease
04/22/2024
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug...
04/22/2024
Advances in Inflammatory Bowel Disease Network
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Post-Menopausal Women With IBD and Hormone Replacement Therapy
04/05/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to...
04/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest Podcasts

IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of ECCO With Dr Frank Farraye
06/12/2024
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of...
06/12/2024
Advances in Inflammatory Bowel Disease Network
Rishika Chugh
Podcast
Rishika Chugh, MD: Safety of Vedolizumab and Ustekinumab in Pregnancy
05/28/2024
Dr Chugh reviews the results of a recent study of the safety of ustekinumab and vedolizumab among pregnant patients with inflammatory bowel disease.
Dr Chugh reviews the results of a recent study of the safety of ustekinumab and vedolizumab among pregnant patients with inflammatory bowel disease.
Dr Chugh reviews the results of...
05/28/2024
Advances in Inflammatory Bowel Disease Network
Noa Cleveland
Podcast
Noa Krugliak Cleveland, MD, on Intestinal Ultrasound in Clinical Practice
05/22/2024
Dr Krugliak Cleveland reviews the results of research and real-world experience in using intestinal ultrasound in clinical practice when diagnosing and monitoring inflammatory bowel disease.
Dr Krugliak Cleveland reviews the results of research and real-world experience in using intestinal ultrasound in clinical practice when diagnosing and monitoring inflammatory bowel disease.
Dr Krugliak Cleveland reviews...
05/22/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Gary Lichtenstein, MD, on the Best of ECCO
05/06/2024
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its...
05/06/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Siddharth Singh: AGA Guidelines on Using Biomarkers in Ulcerative Colitis
04/25/2024
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive...
04/25/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement